by Jessica Lao | Nov 19, 2018 | PMM2-CDG |
This is a continuation of a previous post, which covered Figures 1 – 4 of Perlara’s preprint on bioRxiv, describing our work in modeling PMM2 patient alleles. This work is currently under review at the Genetics Society of America’s peer-reviewed...
by Jessica Lao | Nov 19, 2018 | PMM2-CDG |
Last September, we submitted Perlara’s second preprint to bioRxiv describing our yeast models of PMM2 deficiency. This work is currently under review at the Genetics Society of America’s peer-reviewed journal G3. Below is the description of the figures from the...
by Jessica Lao | Oct 19, 2018 | Rare Diseases |
The 2018 Yeast Genetics Meeting (#Yeast18) was held in August at Stanford University in Palo Alto. I learned about the latest developments in research and advances in tools and technology, reconnected with former colleagues, and established new connections and...
by Naz Dana | Sep 26, 2018 | Business |
Since the spring, our blog has featured regular posts introducing Perlara team members who weren’t a part of the founding team. From recent hires to a long-time team member, from two senior scientists to two research associates, we’ve covered almost...
by Ethan Perlstein | Sep 20, 2018 | PMM2-CDG |
Last week, we posted a preprint describing new yeast models of Phosphomannomutase 2 Deficiency, or PMM2-CDG, the most common congenital disorder of glycosylation in the world. This PMM2 model preprint is our second preprint on bioRxiv which, for the uninitiated, is...
